The 3DEXPERIENCE platform enables businesses to transition from historical and outdated practices to a connected and transformative environment. By focusing on the therapeutic lifecycle, the platform creates a seamless and continuous data flow to facilitate accelerated approvals, in line with the International Conference on Harmonisation paper “Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.” The transparency between early clinical activity, through manufacturing, and on to full commercialization is essential to this success. License to Cure for BioPharma also provides decision and process traceability across all variations and changes at both the product and country level to streamline packaging processes. License to Cure for BioPharma delivers a connected and comprehensive regulatory and quality platform to accelerate therapeutic approval, production, and patient adoption in a global landscape.
Key Highlights & Benefits:
Manage primary & secondary packaging.
Ensure compliance with decision & process traceability.
Manage all variations and changes to the package and label for all international versions.
Streamline packaging process through collaboration including bill of labeling, artwork and change management.